Thousands of patients to benefit from new daily pill for serious heart condition following co-ordinated MHRA and NICE decisions
Around 6,600 people in England with a serious heart condition will be able to access a new treatment following simultaneous MHRA authorisation and NICE approval. Aficamten, also known as MYQORZO, is a once-daily pill for people with obstructive hypertrophic cardiomyopathy (HCM) – a condition where the heart muscle becomes thickened and stiff, making it harder for the heart to … Read more